^
Association details:
| Biomarker: | No biomarker |
|---|---|
| Cancer: | Waldenstrom Macroglobulinemia |
| Drug: | bortezomib (Proteasome inhibitor) |
| Direction: | Sensitive |
Evidence:
Source:
Excerpt:
For patients who are intolerant to rituximab, subcutaneous bortezomib with dexamethasone can be considered as an alternate option to BDR (see Other Recommended Regimens for Primary Therapy)...